Soluble CD83 reverses alopecia areata via indoleamine 2,3-dioxygenase-mediated regulatory T cell activation
British Journal of Dermatology · 2026
DOI: 10.1093/bjd/ljag274 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Dermatology, 2026. Verfasst von Sheng Wan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou Third People's Hospital, Hangzhou, Chi…. Hauptthemen laut MEDLINE: Antigens, CD, Alopecia Areata, T-Lymphocytes, Regulatory, Indoleamine-Pyrrole 2,3,-Dioxygenase. Die Arbeit nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Major Project of Zhejiang Province, State Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
The primary cause of alopecia areata (AA) is autoimmune-mediated hair follicle destruction, while breakdown of immune tolerance due to disruption of regulatory T cell (Treg) homeostasis critically contributes to this process. However, the factors leading to impairment of Tregs and the effective regulatory pathways in AA remain unclear.
Objectives
To assess the therapeutic effects of soluble CD83 (sCD83) on AA and elucidate the crucial role of sCD83-mediated Treg activation in remodelling the perifollicular microenvironment.
Methods
Blood and scalp tissue were collected from patients with AA and healthy control participants to characterize sCD83 using enzyme-linked immunosorbent assay, flow cytometry and immunofluorescence. Using a graft-induced C3H/HeJ mouse model of AA, the therapeutic effect of sCD83 on early-onset AA was evaluated by haematoxylin and eosin staining, immunofluorescence and flow cytometry. In vitro, human hair follicle organ culture and primary outer root sheath keratinocyte (ORSK) culture were used to clarify the impact of sCD83 on the expression and activity of indoleamine 2,3-dioxygenase (IDO) in hair follicles. Co-culture of ORSKs and peripheral blood mononuclear cells, together with administration of an IDO inhibitor to AA mice, were performed to determine the necessity of IDO for Treg activation. Finally, glutathione S-transferase-pulldown and co-immunoprecipitation assays were used to identify potential sCD83 receptors on ORSKs.
Results
We showed here that patients with AA exhibit sCD83 deficiency, which may be attributed to reduced sCD83 release from dendritic cells, and that serum sCD83 levels are negatively correlated with disease severity. Supplementation with sCD83 in an AA mouse model reversed disease manifestations and promoted Treg proliferation. Mechanistically, IDO activity in ORSKs is essential for sCD83-mediated Treg activation, with thioredoxin potentially serving as an sCD83 receptor to regulate IDO expression.
Conclusions
Our study establishes the functional role of sCD83 in AA, confirms the therapeutic potential of sCD83 supplementation and provides some mechanistic insights.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou Third People's Hospital, Hangzhou, China.
- College of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, China.
ORCID-Profile: Sheng Wan, Yujie Li, Xu Liu, Xiuzu Song
Förderung
- National Natural Science Foundation of China
- Science and Technology Major Project of Zhejiang Province
- State Administration of Traditional Chinese Medicine
Zitieren
APA
Wan, S., Li, Y., Liu, X., & Song, X. (2026). Soluble CD83 reverses alopecia areata via indoleamine 2,3-dioxygenase-mediated regulatory T cell activation. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljag274
Vancouver
Wan S, Li Y, Liu X, Song X. Soluble CD83 reverses alopecia areata via indoleamine 2,3-dioxygenase-mediated regulatory T cell activation. British Journal of Dermatology. 2026. doi:10.1093/bjd/ljag274
BibTeX
@article{Wan2026,
author = {Wan, Sheng and Li, Yujie and Liu, Xu and Song, Xiuzu},
title = {Soluble CD83 reverses alopecia areata via indoleamine 2,3-dioxygenase-mediated regulatory T cell activation},
journal = {British Journal of Dermatology},
year = {2026},
doi = {10.1093/bjd/ljag274}
}
EUVIMED